St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for Stuart M. Essig
+0.69 (1.10%)
Nov 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 63.05 - 63.72
52 week 60.34 - 80.84
Open 63.14
Vol / Avg. 511,000.00/1.67M
Mkt cap 17.99B
P/E 18.07
Div/yield 0.29/1.82
EPS 3.52
Shares 282.66M
Beta 1.32
Inst. own 87%
Jan 26, 2016
Q4 2015 St. Jude Medical Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 10, 2015
St. Jude Medical Inc at Credit Suisse Healthcare Conference
Oct 21, 2015
Q3 2015 St. Jude Medical Inc Earnings Release
Oct 21, 2015
Q3 2015 St. Jude Medical Inc Earnings Call
Sep 16, 2015
St. Jude Medical Inc at Morgan Stanley Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '15) 2015
Net profit margin 16.06% 16.99%
Operating margin 21.96% 20.47%
EBITD margin - 31.31%
Return on average assets 8.31% 9.34%
Return on average equity 22.00% 23.77%
Employees 16,000 -
CDP Score - -


1 Saint Jude Medical Dr
SAINT PAUL, MN 55117-1789
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Officers and directors

Daniel J. Starks Executive Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - Americas Division
Age: 47
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 54
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 51
Bio & Compensation  - Reuters
Michael T. Rousseau President, Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John C. Heinmiller Executive Vice President
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Age: 46
Bio & Compensation  - Reuters
Lisa Malden Andrade Chief Marketing Officer, Vice President
Age: 43
Bio & Compensation  - Reuters
I. Paul Bae Chief Marketing Officer, Vice President - Global Human Resources
Age: 50
Bio & Compensation  - Reuters